Cell softness regulates tumorigenicity and stemness of cancer cells

EMBO J. 2021 Jan 15;40(2):e106123. doi: 10.15252/embj.2020106123. Epub 2020 Dec 4.

Abstract

Identifying and sorting highly tumorigenic and metastatic tumor cells from a heterogeneous cell population is a daunting challenge. Here, we show that microfluidic devices can be used to sort marker-based heterogeneous cancer stem cells (CSC) into mechanically stiff and soft subpopulations. The isolated soft tumor cells (< 400 Pa) but not the stiff ones (> 700 Pa) can form a tumor in immunocompetent mice with 100 cells per inoculation. Notably, only the soft, but not the stiff cells, isolated from CD133+ , ALDH+ , or side population CSCs, are able to form a tumor with only 100 cells in NOD-SCID or immunocompetent mice. The Wnt signaling protein BCL9L is upregulated in soft tumor cells and regulates their stemness and tumorigenicity. Clinically, BCL9L expression is correlated with a worse prognosis. Our findings suggest that the intrinsic softness is a unique marker of highly tumorigenic and metastatic tumor cells.

Keywords: BCL9L; metastasis; microfluidic sorting; soft tumor cells; stemness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen / genetics
  • Aldehyde Dehydrogenase / genetics
  • Animals
  • Carcinogenesis / genetics*
  • Cell Line, Tumor
  • DNA-Binding Proteins / genetics
  • Female
  • Humans
  • MCF-7 Cells
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Inbred NOD
  • Mice, SCID
  • Neoplastic Stem Cells / physiology*
  • Up-Regulation / genetics
  • Wnt Proteins / genetics

Substances

  • AC133 Antigen
  • DNA-Binding Proteins
  • Wnt Proteins
  • Aldehyde Dehydrogenase